Seattle biotech company Immusofthas been granted approval to start clinical trials on its unique treatment for genetic diseases Immusoft announced on Thursday. Immusoft claims to be the first company to be granted approval to utilize the engineered…
Seattle biotech company Immusofthas been granted approval to start clinical trials on its unique treatment for genetic diseases Immusoft announced on Thursday. Immusoft claims to be the first company to be granted approval to utilize the engineered…